OTC · ATMS
Artemis Therapeutics Inc.
Financial Services · Shell Companies
$0.50
Down-$1.39 (-73.65%)
Updated Sep 13, 2026, 4:07 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 55.79M
- P/E ratio
- -21,032.59
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.09K
- Avg. volume
- 1.36K
Price performance
ATMS price history
1M range · 0 trading sessions · Daily adjusted prices
ATMS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ATMS news
The latest Smart Investors Daily articles mentioning ATMS.
Stock researchCompany · Overview
ATMS research
Overview
Company profile and research snapshot.
Company profile
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
